Long‐term humoral immunity decline in hemodialysis patients following severe acute respiratory syndrome coronavirus 2 vaccination: A cohort study

Long‐term humoral immunity decline in hemodialysis patients following severe acute respiratory syndrome coronavirus 2 vaccination: A cohort study

Abstract Background and Aims Dialysis patients are extremely vulnerable to severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection with high rates of hospitalization and mortality rates. In January 2021, the University of Virginia Dialysis Program initiated a program‐wide vaccination...

Full description

Bibliographic Details
Main Authors: Eibhlin Goggins, Binu Sharma, Jennie Z. Ma, Jitendra Gautam, Brendan Bowman
Format: Article
Language:English
Published: Wiley 2022-11-01
Series:Health Science Reports
Subjects:
antibody
COVID‐19 vaccination
end‐stage kidney disease
hemodialysis
humoral immunity
SARS‐CoV‐2
Online Access:https://doi.org/10.1002/hsr2.854

Internet

https://doi.org/10.1002/hsr2.854

Similar Items